HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 191 filers reported holding HAEMONETICS CORP in Q1 2014. The put-call ratio across all filers is 3.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $206,000 | -35.4% | 1,800 | -83.6% | 0.00% | 0.0% |
| Q2 2016 | $319,000 | -96.6% | 11,008 | -95.9% | 0.00% | -97.4% |
| Q1 2016 | $9,423,000 | +7.1% | 269,373 | -1.3% | 0.04% | +5.6% |
| Q4 2015 | $8,801,000 | -35.7% | 272,980 | -35.6% | 0.04% | -39.0% |
| Q3 2015 | $13,694,000 | -39.5% | 423,689 | -22.6% | 0.06% | -31.4% |
| Q2 2015 | $22,632,000 | -47.3% | 547,200 | -42.8% | 0.09% | -54.7% |
| Q1 2015 | $42,981,000 | +2.1% | 956,828 | -15.0% | 0.19% | +6.7% |
| Q4 2014 | $42,102,000 | +1.5% | 1,125,132 | -5.3% | 0.18% | +3.5% |
| Q3 2014 | $41,499,000 | -12.5% | 1,188,415 | -11.5% | 0.17% | -13.1% |
| Q2 2014 | $47,402,000 | -15.4% | 1,343,591 | -21.8% | 0.20% | -20.5% |
| Q1 2014 | $56,007,000 | -29.7% | 1,718,538 | -9.1% | 0.25% | -27.0% |
| Q4 2013 | $79,640,000 | -52.0% | 1,890,342 | -54.5% | 0.34% | -21.1% |
| Q3 2013 | $165,752,000 | +88.4% | 4,156,274 | +95.3% | 0.43% | -9.2% |
| Q2 2013 | $87,997,000 | – | 2,128,100 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |